Recent Advances in Cervical Cancer Treatment & Research
https://vimeo.com/1168250767 Are there advances in cervical cancer treatment that patients should know about? In this video, Dr. Joshua Cohen highlights the latest research, including the increasing role of immunotherapy, newly…
Elevated Expert Advice | Myeloma CAR T-Cell Therapy
https://vimeo.com/1164531878 Myeloma specialist Dr. Ciara Freeman shares hope for the future of myeloma care, encouraging patients and care partners to stay informed, ask bold questions, and connect with a myeloma…
Myeloma CAR T-Cell Therapy | Long-Term Recovery
https://vimeo.com/1164531893 Dr. Ciara Freeman, a myeloma specialist from Moffitt Cancer Center, discusses what to expect in the long term following the CAR T-cell therapy process. Dr. Freeman reviews symptoms to watch…
After CAR T-Cell Therapy | Essential Follow-Up & Testing
https://vimeo.com/1164531905 Can CAR T-cell therapy response deepen over time? Dr. Ciara Freeman, a myeloma specialist from Moffitt Cancer Center, discusses how the effectiveness of treatment is monitored over time, including the…
During and After Myeloma CAR T-Cell Therapy | What to Expect
https://vimeo.com/1164531913 Dr. Ciara Freeman, a myeloma specialist from Moffitt Cancer Center, helps patients and care partners understand the day-to-day reality of CAR T-cell therapy. Dr. Freeman provides an overview of…
Preparing for Myeloma CAR-T Cell Therapy | What to Expect
https://vimeo.com/1164531947 Dr. Ciara Freeman provides an overview of what patients and care partners can expect before CAR T-cell therapy—from deciding if CAR T is right for you to getting physically…
How Has Myeloma CAR T-Cell Therapy Changed in Recent Years?
https://vimeo.com/1164531973 Dr. Ciara Freeman, a myeloma specialist from Moffitt Cancer Center, explains CAR T-cell therapy in simple terms, sharing how this treatment is changing the future for people with myeloma….
Research Updates From ASH | Myeloma CAR T-Cell Therapy
https://vimeo.com/1164531982 Myeloma expert and researcher Dr. Ciara Freeman shares key CAR T-cell therapy advances presented at the 2025 American Society of Hematology (ASH) meeting. Dr. Freeman also provides an explanation…
复发后的骨髓瘤：新研究对患者的意义
https://vimeo.com/1160266766 德克萨斯大学MD安德森癌症中心的Krina K. Patel医学博士讨论了MAJESTIC-3临床试验中令人鼓舞的新数据，该研究针对首次复发后的多发性骨髓瘤患者，评估了两种免疫疗法联合使用的效果。她解释了这种治疗方法的工作原理、为何研究结果如此令人振奋，以及为何支持性治疗对于安全管理治疗至关重要。Patel医生还分享了实用见解，帮助患者理解这一治疗选择在其整体治疗路径中的潜在定位，在带来希望的同时，强调经过深思熟虑的个体化决策的重要性。 See More from [ACT]IVATED Multiple Myeloma Related Resources What Are Myeloma Risk Factors for Veterans and First Responders? How AI Is Shaping the Future of CAR…
Mieloma Después de la Recaída: Lo Que la Nueva Investigación Significa para los Pacientes
https://vimeo.com/1160265495 La Dra. Krina K. Patel del Centro de Cáncer MD Anderson de la Universidad de Texas analiza datos alentadores del ensayo clínico MAJESTIC-3, que estudió una combinación de dos…
Myeloma After Relapse: What New Research Means for Patients
https://vimeo.com/1160264387 Dr. Krina K. Patel of The University of MD Anderson Cancer Center discusses encouraging new data from the MAJESTIC-3 clinical trial, which studied a combination of two immunotherapies for…
¿Por Qué Importa la Representación en los Ensayos Clínicos de Cáncer de Próstata?
https://vimeo.com/1160173617 ¿Por qué importa la inclusión en los ensayos clínicos de cáncer de próstata, y cómo pueden los pacientes ayudar a impulsar el cambio? En este segmento de [ACT]IVATED, la…